Expression of matrix metalloproteinase 1 in tissue of colon carcinoma and its clinical prognostic significance

National Medical Journal of China

Volumn 91, Issue 41, 2011, Pages 2895-2898

  Lu, Zhen Hai ^a   Fang, Yu Jing ^a   Wu, Xiao Jun ^a   Pan, Zhi Zhong ^a   Wan, De Sen ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Colonic neoplasms; Matrix metalloproteinase 1; Neoplasm staging; Prognosis

Indexed keywords

INTERSTITIAL COLLAGENASE; MMP1 PROTEIN, HUMAN;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY; ADOLESCENT; ADULT; AGED; CHILD; COLON TUMOR; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84871263464     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.41.005     Document Type: Article

References (13)

1. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin, 2004, 54: 295-308.
2. Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol, 2005, 23: 3526-3535.
3. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol, 1990, 1: 99-106.
4. 2000, 19: 1068-1071.
5. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
6. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem, 1999, 274: 21491-21494.
7. Harris E. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med, 1990, 322: 1277-1289.
8. Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie, 2005, 87: 273-286.
9. Liabakk NB, Talbot I, Smith RA, et al. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenase in colorectal cancer. Cancer Res, 1996, 56: 190-196.
10. Murray G, Duncan M, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med, 1996, 2: 461-462.
11. Ohmachi T, Tanaka F, Mimori K, et al. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res, 2006, 12: 3057-3063.
12. Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res, 1999, 5: 1966-1975.
13. Mucci Nr, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol, 2000, 31: 406-414.